The phosphatidylinositol 3-kinase-δ Inhibitor CAL-101 demonstrates promising pre-clinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals
暂无分享,去创建一个
Jeffrey A Jones | Weiqiang | J. Byrd | N. Heerema | A. Johnson | L. Andritsos | J. Flynn | Lai Wei | N. Giese | K. Puri | Xiaoli Zhang | S. E. Herman | B. Lannutti | A. J. Wagner | Amber L. Gordon | Zhao | Amy J. Wagner | Xiaoli Zhang